Candida Intertrigo
Understand Candida Intertrigo, also known as Candidal Intertrigo and Intertriginous Candidiasis. This resource provides information on diagnosis, clinical documentation, and medical coding for healthcare professionals. Learn about symptoms, treatment, and best practices for managing Candida Intertrigo in clinical settings. Find relevant information for accurate medical coding and improved patient care.
Fungal skin infection in skin folds caused by Candida species.
Red, itchy rash in warm, moist areas like armpits, groin, or under breasts. May have white patches or satellite lesions.
Obesity, diabetes, antibiotic use, warm humid climates.
ICD-10 Code Families
Complete code families applicable to B37.2
When to use each related code
| Description | When to use |
|---|---|
| Yeast infection in skin folds. | Red, itchy rash in warm, moist areas like armpits, groin. Satellite lesions may be present. Confirmed by KOH prep. |
| Bacterial skin infection in folds. | Skin fold infection with malodor, no satellite lesions. Consider if KOH is negative for Candida. |
| Allergic skin inflammation. | Itchy, red, dry, possibly scaly rash in flexural areas, often chronic. No satellite lesions. Consider personal or family history of atopy. |
Best-practice checklist
- ✓Document affected intertriginous area(s).
- ✓Describe lesion morphology (e.g., erythema, satellite lesions).
- ✓Note presence of pruritus, burning, or pain.
- ✓Document KOH prep results if performed.
- ✓Record patient's risk factors (e.g., obesity, diabetes).
Common pitfalls to avoid
Coding Candida intertrigo without specifying the affected body area can lead to claim rejection. CDI queries may be necessary for clarification.
Confusing Candida intertrigo with other skin conditions like eczema or psoriasis can impact coding accuracy and reimbursement. Proper documentation is crucial.
Failing to code associated conditions like diabetes or obesity, which can exacerbate Candida intertrigo, may affect risk adjustment and quality reporting.
Best-practice tips
- 01Keep skin folds clean and dry. ICD-10: B37.1, L21.8
- 02Apply antifungal powder or cream. SNOMED CT: 400269007
- 03Wear loose, breathable clothing. Improve CDI: Skin hygiene
- 04Avoid harsh soaps and irritants. HCC coding: Risk adjustment
- 05Manage underlying diabetes if present. ICD-10: E11
Step-by-step checklist
- 1
Confirm intertriginous rash: erythematous, macerated.
- 2
Satellite lesions or pustules present? Document specifics.
- 3
KOH microscopy: pseudohyphae and/or budding yeast.
- 4
Consider comorbidities: obesity, diabetes, antibiotics.
Ready-to-paste narrative
Patient presents with intertrigo, consistent with Candida intertriginous infection. Affected area located in [specify body folds, e.g., inguinal folds, axillae, inframammary folds, gluteal cleft]. Clinical findings include erythematous plaques with satellite lesions and maceration. Patient reports [pruritus, burning, or pain]. Differential diagnosis includes seborrheic dermatitis, inverse psoriasis, contact dermatitis, and erythrasma. Diagnosis of candidal intertrigo based on clinical presentation and KOH preparation showing pseudohyphae and budding yeast. Risk factors discussed with the patient include obesity, diabetes, antibiotic use, and immunocompromised states. Treatment plan includes topical antifungal cream [specify medication, e.g., clotrimazole, miconazole, ketoconazole] applied to affected area twice daily for [duration]. Patient education provided on maintaining skin hygiene, keeping affected areas dry, and proper application of topical medication. Follow-up scheduled in [timeframe] to assess treatment response. ICD-10 code B37.8.
Common questions and answers
How can I differentiate Candida intertrigo from other intertriginous dermatoses like inverse psoriasis or erythrasma in a clinical setting?+
Differentiating Candida intertrigo from other intertriginous dermatoses requires careful clinical evaluation. While all present with erythema and inflammation in skin folds, key distinctions exist. Candida intertrigo often exhibits satellite papules and pustules extending beyond the main affected area, along with a characteristic whitish, macerated appearance. Inverse psoriasis typically presents with sharply demarcated, smooth, shiny plaques lacking the satellite lesions. Erythrasma, a bacterial infection, exhibits a reddish-brown hue with fine scaling and often fluoresces coral red under a Wood's lamp. Microscopic examination with KOH preparation can confirm the presence of Candida yeast in intertrigo. Consider implementing a stepwise approach incorporating clinical features, Wood's lamp examination, and KOH microscopy for accurate diagnosis. Explore how different diagnostic tests can aid in distinguishing these conditions.
What are the best topical antifungal treatment options for managing recurrent Candida intertrigo in obese patients, considering factors like skin fold occlusion and potential drug interactions?+
Managing recurrent Candida intertrigo in obese patients requires addressing the underlying predisposing factors, particularly skin fold occlusion and moisture. Topical antifungals are the mainstay of treatment. Nystatin powder or cream can be effective but may be less potent than azole antifungals like clotrimazole, miconazole, or ketoconazole. For resistant cases or severe inflammation, a short course of topical corticosteroids combined with an antifungal can be considered. Ensure patients understand the importance of keeping the affected area clean and dry. Absorbent powders can help reduce moisture. In obese patients, explore weight management strategies as part of long-term management. Learn more about the role of lifestyle modifications in preventing intertrigo recurrence and minimizing potential drug interactions with other medications commonly used in this population.
Beyond topical antifungals, what adjunctive therapies or preventative measures can be employed to effectively manage Candida intertrigo and prevent recurrence, especially in patients with diabetes?+
In patients with diabetes, meticulous glycemic control is crucial for preventing and managing Candida intertrigo, as hyperglycemia promotes yeast overgrowth. Alongside topical antifungal therapy, consider implementing adjunctive measures like keeping skin folds clean and dry, using absorbent powders, and wearing loose-fitting clothing. Avoiding prolonged exposure to moisture and heat is essential. Educate patients about proper hygiene practices, emphasizing the importance of thoroughly drying skin folds after bathing or sweating. For severe or recurrent cases, consider consultation with a dermatologist or infectious disease specialist. Explore how interprofessional collaboration can improve patient outcomes in managing intertrigo and its associated complications in patients with diabetes.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.